RANDOMIZED CONTROLLED TRIAL
Add like
Add dislike
Add to saved papers

A 2.5 min cold water immersion improves prolonged intermittent sprint performance.

OBJECTIVES: We investigated if cold water immersion (CWI) affects exercise performance during a prolonged intermittent sprint test (IST), designed to mimic activity patterns of team-sports.

DESIGN: Randomized-crossover design.

METHODS: Ten male team-sport players completed 3 IST protocols (two 40-min "halves" of repeated 2-min blocks consisting of a 8-s "all-out" sprint, 100-s active recovery and 12-s rest) on a cycle ergometer at normothermic conditions. Each "half" was separated by a 15 min recovery period of either: (i) passive rest, (ii) 5-min CWI at 8 °C (CWI-5) or (iii) 2.5-min CWI at 8 °C (CWI-2.5), in a random counterbalanced order.

RESULTS: Physical performance, core temperature (Tcore ) and heart rate were not different among conditions in the first half. In the passive rest trial, total work (TW) and peak power (PP) were lower during the second half (TW: 5.04 ± 1.11 kJ; PP: 929 ± 286 W) than the first half (TW: 5.66 ± 1.02 kJ; PP: 1009 ± 266 W); while TW and PP were not different between halves following CWI-5 (first half, TW: 5.34 ± 1.02 kJ, PP: 1016 ± 283 W; second half, TW: 5.19 ± 1.38 kJ; PP: 996 ± 318 W) and CWI-2.5 (first half, TW: 5.47 ± 1.19 kJ, PP: 966 ± 261 W; second half, TW: 5.25 ± 1.17 kJ; PP: 952 ± 231 W). Tcore was lower until the 20th minute of the second half after CWI-5 and CWI-2.5 compared with passive rest.

CONCLUSIONS: A post-exercise 2.5-5-min CWI attenuates the reductions in prolonged sprint performance that occur in the second half of team sports, due, at least partly, to reductions in core temperature and associated increase in heat storage.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app